Narcolepsy and obesity: Remission of severe cataplexy with sibutramine

Sleep Medicine

Volumn 2, Issue 1, 2001, Pages 63-65

  Krahn, L E ^a   Moore, W R ^a   Altchuler, S I ^a  

^a MAYO CLINIC   (United States)

Author keywords

Monamines; Narcolepsy; Obesity; Sibutramine; Sleep

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIOBESITY AGENT; METHYLPHENIDATE; MODAFINIL; OREXIN A; PEMOLINE; SIBUTRAMINE;

ACTIMETRY; ADOLESCENT; ALERTNESS; ANXIETY; AREFLEXIA; ARTICLE; CASE REPORT; CATAPLEXY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG EFFECT; DRUG RESPONSE; DRUG USE; FEMALE; HALLUCINATION; HUMAN; LATENT PERIOD; LOW CALORY DIET; NARCOLEPSY; NAUSEA; NERVOUSNESS; NIGHT SLEEP; OBESITY; PARASOMNIA; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; REM SLEEP; REMISSION; SIDE EFFECT; SLEEP APNEA SYNDROME; SOMNOLENCE; VOCALIZATION; WEIGHT REDUCTION;

EID: 0035120036     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(00)00056-3     Document Type: Article

References (10)

1. Hypocretin (orexin) deficiency in human narcolepsy
2. A standardized test for cataplexy
3. Treatment of cataplexy with clomipramine
4. Clinical aspects and features of cataplexy. Negative motor phenomena
5. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: Double-blind subjective measures
6. Absence of cardiac valve dysfunction in obese patients treated with sibutramine
7. Long-term maintenance of weight loss after a very low calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine
8. Sibutramine pharmakinetics in young and elderly healthy subjects
9. Sibutramine. A review of its contribution to the management of obesity
10. Sibutramine: A serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity